These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20474325)

  • 1. On the Danysz Effect with reference to the Toxin-Antitoxin Reaction.
    Craw JA
    J Hyg (Lond); 1907 Jul; 7(4):501-11. PubMed ID: 20474325
    [No Abstract]   [Full Text] [Related]  

  • 2. On the Danysz Effect with reference to the Toxin-antitoxin Reaction.
    Craw JA
    J Hyg (Lond); 1909 Apr; 9(1):46-59. PubMed ID: 20474385
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunochemical studies of antitoxin produced in normal and allergic individuals hyperimmunized with diphtheria toxoid. II. A comparison between the immunological properties of precipitating and non-precipitating (skin-sensitizing) antitoxins.
    KUHNS WJ; PAPPENHEIMER AM
    J Exp Med; 1952 Apr; 95(4):375-92. PubMed ID: 14938507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STUDIES ON THE MOLECULAR WEIGHT OF DIPHTHERIA TOXIN, ANTITOXIN, AND THEIR REACTION PRODUCTS.
    Pappenheimer AM; Lundgren HP; Williams JW
    J Exp Med; 1940 Jan; 71(2):247-62. PubMed ID: 19870960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACTIVE IMMUNITY PRODUCED BY SO CALLED BALANCED OR NEUTRAL MIXTURES OF DIPHTHERIA TOXIN AND ANTITOXIN.
    Smith T
    J Exp Med; 1909 Mar; 11(2):241-56. PubMed ID: 19867246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A QUANTITATIVE STUDY OF THE SCARLET FEVER TOXIN-ANTITOXIN FLOCCULATION REACTION.
    Hottle GA; Pappenheimer AM
    J Exp Med; 1941 Nov; 74(6):545-56. PubMed ID: 19871154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. parD toxin-antitoxin system of plasmid R1--basic contributions, biotechnological applications and relationships with closely-related toxin-antitoxin systems.
    Diago-Navarro E; Hernandez-Arriaga AM; López-Villarejo J; Muñoz-Gómez AJ; Kamphuis MB; Boelens R; Lemonnier M; Díaz-Orejas R
    FEBS J; 2010 Aug; 277(15):3097-117. PubMed ID: 20569269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of low tetanus or diphtheria antitoxin titers in sera by a toxin neutralization assay and a modified toxin-binding inhibition test.
    Sonobe MH; Trezena AG; Guilhen FB; Takano VL; Fratelli F; Sakauchi D; Morais JF; Prado SM; Higashi HG
    Braz J Med Biol Res; 2007 Jan; 40(1):69-76. PubMed ID: 17224998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteic toxin-antitoxin, bacterial plasmid addiction systems and their evolution with special reference to the pas system of pTF-FC2.
    Rawlings DE
    FEMS Microbiol Lett; 1999 Jul; 176(2):269-77. PubMed ID: 10427709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of four type II toxin-antitoxin systems in Actinobacillus pleuropneumoniae.
    Zheng C; Zhao X; Zeng T; Cao M; Xu J; Shi G; Li J; Chen H; Bei W
    FEMS Microbiol Lett; 2017 Jul; 364(12):. PubMed ID: 28637172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in immunological responses of polyclonal botulinum A1 and A2 antitoxin against A1 and A2 toxin.
    Torii Y; Shinmura M; Kohda T; Kozaki S; Takahashi M; Ginnaga A
    Toxicon; 2013 Oct; 73():9-16. PubMed ID: 23834917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro Toxin-Binding Inhibition (ToBI) test.
    Hendriksen CF; van der Gun JW; Kreeftenberg JG
    J Biol Stand; 1989 Apr; 17(2):191-200. PubMed ID: 2715153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Cysteine Protease MaOC1, a Prokaryotic Caspase Homolog, Cleaves the Antitoxin of a Type II Toxin-Antitoxin System.
    Klemenčič M; Halužan Vasle A; Dolinar M
    Front Microbiol; 2021; 12():635684. PubMed ID: 33679669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational Methods to Model Persistence.
    Vandervelde A; Loris R; Danckaert J; Gelens L
    Methods Mol Biol; 2016; 1333():207-40. PubMed ID: 26468111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of circulating toxin and antitoxin in unimmunized tetanus cases of neonates and infants.
    Grover SS; Negi SS; Singh S; Ray K
    Biologicals; 2012 Jul; 40(4):262-5. PubMed ID: 22464049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hipBA
    Yadav M; Rathore JS
    Appl Microbiol Biotechnol; 2020 Apr; 104(7):3081-3095. PubMed ID: 32043192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxin-antitoxin systems and their medical applications: current status and future perspective.
    Srivastava A; Pati S; Kaushik H; Singh S; Garg LC
    Appl Microbiol Biotechnol; 2021 Mar; 105(5):1803-1821. PubMed ID: 33582835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A regulatory role for Staphylococcus aureus toxin-antitoxin system PemIKSa.
    Bukowski M; Lyzen R; Helbin WM; Bonar E; Szalewska-Palasz A; Wegrzyn G; Dubin G; Dubin A; Wladyka B
    Nat Commun; 2013; 4():2012. PubMed ID: 23774061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting yoeB-yefM toxin-antitoxin system of Streptococcus pneumoniae on the selective killing of miR-21 overexpressing breast cancer cell line (MCF-7).
    Houri H; Ghalavand Z; Faghihloo E; Fallah F; Mohammadi-Yeganeh S
    J Cell Physiol; 2020 Mar; 235(3):2925-2936. PubMed ID: 31541457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.